Advertisement

Topics

Search Results for "Takeda"

09:27 EDT 17th October 2017 | BioPortfolio

Matching Channels

Pertussis Vaccine acellular Takeda

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based Assays for ...

For SGC and KI:Michael Sundström, Scientific DirectorMichael.sundstrom@ki.se+46 79 65 44 662KI press office: +46 8 524 860 77orFor Takeda:Tsuyoshi Tada – Japantsuyoshi.tada@takeda....

Takeda Research Investment: How Investments are Chosen

In this episode of PharmaTelevision News Review, Fintan Walton talks with Graeme Martin, President & CEO at Takeda Research Investment. Filmed at BioTrinity 2010 in Newbury, UK, they discuss: • TRI...

Takeda make a strategic acquisition

In this episode of PharmaTelevision News Review, Fintan Walton talks to Nigel Borshell, Director at PharmaVentures. Nycomed’s geographic presence in Europe and Emerging markets a strong justificati...

Takeda and Shattuck Labs Announce Research Collaboration to Explore Agonist Redirected ...

Takeda Contact:Kelly Schlemm – USAkelly.schlemm@takeda.com+1-617-551-8865orShattuck Contact:Josiah Hornblowerjhornblower@shattucklabs.com Read more...

Takeda options programs discovered through Schrodinger alliance

Takeda Pharmaceutical Co. Ltd. and drug discovery firm Schrodinger Inc. penned a multi-year, multi-target deal focused on Takeda’s core therapy areas.

Nektar and Takeda enter into trial collaboration for myeloma, lymphoma, and colorectal cancer

Nektar Therapeutics and Takeda Pharmaceutical Co. Ltd., through its Takeda Oncology/Millennium Pharmaceuticals division, entered into a trial collaboration to explore the combination of Nektar’s NKT...

Recursion, Takeda Ink $90 Million AI R&D Pact

Recursion Announces Research Collaboration with Takeda to Rapidly Build a Rare Disease PipelineCollaboration to leverage Recursion's AI-augmented phenotypic discovery platform, and Takeda's TAK-celera...

Takeda Ventures Inc: Graeme Martin. Extending Takeda’s reach into the Global scientific community

In this episode of PharmaTelevision News Review, filmed at BioTrinity 2013, Newbury UK, Fintan Walton speaks to Graeme Martin, President and CEO of Takeda Ventures Inc.

Matching PubMed Articles

Video Comment on Kenichi Takeda et al.

Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.

Bile acids play a critical role in the regulation of glucose, lipid and energy metabolisms by activating the nuclear bile acid receptor farnesoid X receptor (FXR) and membrane G protein-coupled bile a...

Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD.

Bile acids are signaling molecules, which coordinately regulate metabolism and inflammation via the nuclear farnesoid X receptor (FXR) and the Takeda G protein-coupled receptor 5 (TGR5). These recepto...

Limited Transmission Potential of Takeda's Tetravalent Dengue Vaccine Candidate by Aedes albopictus.

Recombinant live-attenuated chimeric tetravalent dengue vaccine viruses, TDV-1, -2, -3, and -4, contain the premembrane and envelope genes of dengue virus serotypes 1-4 in the replicative background o...

Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats.

Glycyrrhizic acid (GA) is belonged to triterpenoid saponin that is contained in the root of licorice and is known to affect metabolic regulation. Recently, glucagon like peptide-1 (GLP-1) has widely b...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement